Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: Implications for disease pathogenesis

Journal of Alzheimer's Disease

Volumn 9, Issue 1, 2006, Pages 51-58

  Grammas, Paula ^a   Samany, Pezhman Ghatreh ^a   Thirumangalakudi, Lakshmi ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Inflammation; Microvessels; Neurotoxin; Vascular

Indexed keywords

ALPHA5 INTEGRIN; ALPHAVBETA5 INTEGRIN; BETA5 INTEGRIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; PROTEIN; THROMBIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN MICROCIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; MICROVASCULATURE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 33646014454     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9105     Document Type: Article

References (69)

1. H. Akiyama, K. Ikeda, H. Kondo and P.L. McGeer, Thrombin accumulation in brains of patients with Alzheimer's disease, Neurosci Lett 146 (1992), 152-154.
2. K.L. Anderson and A. Ferreira, alpha 1 Integrin activation: a link between beta-amyloid deposition and neuronal death in aging hippocampal neurons, J Neurosci Res 75 (2004), 688-697.
3. M. Aslan and T. Ozben, Reactive oxygen and nitrogen species in Alzheimer's disease, Curr Alzheimer Res 1 (2004), 111-119.
4. N.G. Bazan, R. Palacios-Pelaez and W.J. Lukiw, Hypoxia signaling to genes: significance in Alzheimer's disease, Mol Neurobiol 26 (2002), 283-298.
5. S. Bazan-Socha, A. Bukiej, C. Marcinkiewicz and J. Musial, Integrins in pulmonary inflammatory diseases, Curr Pharm Des 11 (2005), 893-901.
6. R.S. BelAiba, T. Djordjevic, S. Bonello, D. Flugel, J. Hess, T. Kietzman and A. Gorlach, Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells, Biol Chem 385 (2004), 249-257.
7. L. Bello, M. Francolini, P. Marthyn, J. Zhang, R.S. Carroll, D.C. Nikas, J.F. Strasser, R. Villani, D.A. Cheresh and P.M. Black, Alpha (v) beta3 and alpha (v) beta5 integrin expression in glioma periphery, Neurosurgery 49 (2001), 659-665.
8. C. Bozzo, G. Lombardi, C. Santoro and P.L. Canonico, Involvement of beta (1) integrin in betaAP-induced apoptosis in human neuroblastoma cells, Mol Cell Neurosci 25 (2004), 1-8.
9. J.R. Ciallella, H. Figueiredo, V. Smith-Swintosky and J.P. McGillis, Thrombin induces surface and intracellular secretion of amyloid precursor protein from human endothelial cells, Thromb Haemost 81 (1999), 630-637.
10. S.J. Cleland, N. Sattar, J.R. Petrie, N.G. Forouhi, H.L. Elliot and J.M. Connell, Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease, Clin Sci 98 (2000), 531-535.
11. M. Crisby, L.A. Carlson and B. Winblad, Statins in the prevention and treatment of Alzheimer disease, Alzheimer Dis Assoc Disord 16 (2002), 131-136.
12. J.C. de la Torre, Alzheimer disease as a vascular disorder: nosological evidence, Stroke 33 (2002), 1152-1162.
13. J.C. de la Torre and G.B. Stefano, Evidence that Alzheimer's disease is microvascular disorder: the role of constitutive nitric oxide, Brain Res Rev 34 (2000), 119-136.
14. C.A. Diglio, P. Grammas, F. Giacomelli and J. Wiener, Primary culture of rat cerebral microvascular endothelial cells, Lab Invest 46 (1982), 554-563.
15. C.A. Diglio, W. Liu, P. Grammas, F. Giacomelli and J. Wiener, Isolation and characterization of cerebral resistance vessel endothelium in culture, Tissue and Cell 25 (1993), 833-846.
16. M.A. Dorheim, W.R.Tracey, J.S. Pollock and P. Grammas, Nitric oxide is elevated in Alzheimer's brain microvessels, Biochem Biophys Res Comm 205 (1994), 659-665.
17. T. Duong, M. Nikolaeva and P.J. Acton, C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease, Brain Res 749 (1997), 152-156.
18. E. Dupuy, A. Habib, M. Lebret, R. Yang, S. Levy-Toledano and G. Tobelem, Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha, J Thromb Haemost 1 (2003), 1096-1102.
19. D.B. Ellegala, H. Leong-Poi, J.E. Carpenter, A.L. Klibanov, S. Kaul, M.E. Shaffrey, J. Sklenar and J.R. Lindner, Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3, Circulation 108 (2003), 336-341.
20. B.W. Festoff, M.R. D'Andrea, B.A. Citron, R.M. Salcedo, I.V. Smirnova and P. Andrade-Gordon, Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein coupled, protease-activated receptor for thrombin, Mol Med 6 (2000), 410-429.
21. J.L. Gerst, A.K. Raina, I. Pirim, A. McShea, P.L. Harris, S.L.Siedlak, A. Takeda, R.B. Petersen and M.A. Smith, Altered cell-matrix associated ADAM proteins in Alzheimer disease, J Neurosci Res 59 (2000), 680-684.
22. P. Grammas, A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease, Neurobiol Aging 21 (2000), 199-205.
23. P. Grammas, P. Moore and P.H. Weigel, Alzheimer's disease brain microvessels kill neurons in vitro, Am J Pathol 154 (1999), 337-342.
24. P. Grammas, T. Ottman, U. Reimann-Philipp, J. Larabee and P.H. Weigel, Injured brain endothelial cells release neurotoxic thrombin, J Alz Dis 6 (2004), 275-281.
25. P. Grammas and R. Ovase, Inflammatory factors are elevated in brain microvessels in Alzheimer's disease, Neurobiol Aging 22 (2001), 837-842.
26. P. Grammas, A.E. Roher and M.J. Ball, Decreased α-adrenergic receptors at the blood-brain barrier in Alzheimer's disease, in: In Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, K. Iqbal, D.R.C. McLachlan, B. Winblad and H.M. Wisniewski, eds, John Wiley & Sons., Ltd., 1991, pp. 129-136.
27. M.S. Grotewiel, C.D. Beck, K.H. Wu, X.R. Zhu and R.L. Davis, Integrin-mediated short-term memory in Drosophila, Nature 391 (1998), 455-460.
28. G.C. Haralabopoulos, D.S. Grant, H.K. Kleinman and M.E. Maragoudakis, Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo, Am J Physiol 272 (1997), 239-245.
29. K. Herrup, R. Neve, S.L. Ackerman and A. Copani, Divide and die: cell cycle events as triggers of nerve cell death, J Neurosci 24 (2004), 9232-9239.
30. G.J. Ho, R. Drego, E. Hakimian and E. Masliah, Mechanisms of cell signaling and inflammation in Alzheimer's disease, Curr Drug Targets Inflamm Allergy 4 (2005), 247-256.
31. Y.-Q. Huang, J.-J. Li, L. Lu, M. Lee and S. Karpatkin, Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells, Blood 99 (2002), 1646-1650.
32. F. Jung, L.A. Palmer, N. Zhou and R.A. Johns, Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes, Circ Res 86 (2000), 319-325.
33. B. Kaur, F.W. Khwaja, E.A. Severson, S.L. Matheny, D.J. Brat and E.G. Van Meir, Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis, Neuro-oncol 7 (2005), 134-153.
34. H. Kimura and H. Esumi, Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis, Acta Biochim Pol 50 (2003), 49-59.
35. T. Kong, H.K. Eltzschig, J. Karhausen, S.P. Colgan and C.S. Shelley, Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression, Proc Natl Acad Sci USA 101 (2004), 10440-10445.
36. L. Liu and G.M. Rodgers, Characterization of an inducible endothelial cell prothrombin activator, Blood 88 (1996), 2989-2994.
37. L.F. Lue, R. Rydel, E.F. Brigham, L.B. Yang, H. Hampel, G.M. Murphy, Jr., L. Brachova, S.D. Yan, D.G. Walker, Y. Shen and J. Rogers, Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro, Glia 35 (2001), 72-79.
38. M. E. Margoudakis, N.E. Tsopanoglou and P. Andriopoulou, Mechanism of thrombin-induced angiogenesis, Biochem Soc Trans 30 (2002), 173-177.
39. P.L. McGeer, A. Klegeris, D.G. Walker, O, Yasuhara and E.G. McGeer, Pathological proteins in senile plaques, Tohoku J Exp Med 174 (1994), 269-277.
40. T. Menge, H.P. Hartung and O. Stuve, Statins-a cure-all for the brain?, Nat Rev Neurosci 6 (2005), 325-331.
41. D.L. Merkle, C.H. Cheng, F.J. Castellino and B.A. Chibber, Modulation of fibrin assembly and polymerization by the beta-amyloid of Alzheimer's disease, Blood Coagul Fibrinolysis 7 (1996), 650-658.
42. M. Mhatre, A. Nguyen, T. Pham, A. Adesina and P. Grammas, Thrombin, a mediator of neurotoxicity and memory impairment, Neurobiol Aging 25 (2004), 783-793.
43. J. Miklossy, Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease, Neurol Res 25 (2003), 605-610.
44. R. Milner and I.L. Campbell, The integrin family of cell adhesion molecules has multiple functions within the CNS, J Neurosci Res 69 (2002), 286-291.
45. Neuroinflammation Working Group, Inflammation and Alzheimer's disease, Neurobiol Aging 21 (2000), 383-421.
46. S. Ogawa, R. Shreeniwas, J. Brett, M. Clauss, M. Furie and D.M. Stern, The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function, Br J Haematol 75 (1990), 517-524.
47. I. Oynebraten, O. Bakke, P. Brandtzaeg, F.E. Johansen and G. Haraldsen, Rapid chemokines secretion from endothelial cells orginates from 2 distinct compartments, Blood 15 (2004), 314-320.
48. K. Pansari, A. Gupta and P. Thomas, Alzheimer's disease and vascular factors: facts and theories, Int J Clin Pract 56 (2002), 197-203.
49. H.A. Pereira, P. Kumar and P. Grammas, Expression of CAP37, a novel inflammatory mediator in Alzheimer's disease, Neurobiol Aging 17 (1996), 753-759.
50. C.W. Pugh and P.J. Ratcliffe, Regulation of angiogenesis by hypoxia: role of the HIF system, Nat Med 9 (2003), 677-684.
51. U. Reimann-Philipp, R. Ovase, M. Lapus, P.H. Weigel and P. Grammas, Mechanisms of cell death in primary cortical neurons and PC12 cells, J Neurosci Res 64 (2001), 654-660.
52. A.E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D.C. Luehrs, J.D. Seward, L.I. Su and T.G. Beach, Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease, Arterioscler Thromb Vasc Biol 23 (2003), 2055-2062.
53. J. Rohrbough, M.S. Grotewiel, R.L. Davis and K. Broadie, Integrin-mediated regulation of synaptic morphology, transmission, and plasticity, J Neurosci 20 (2000), 6868-6878.
54. F.M. Sacks, P. Alaupovic, L.A. Moye, T.G.Cole, B. Sussez, M.J. Stampfer, M.A. Pfeffer and E. Braunwald, VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent event (CARE) trial, Circulation 102 (2000), 1886-1892.
55. N. Savion, J.D. Isaacs, D. Gospodarowicz and M.A. Shuman, Internatlization and degradation of thrombin and up regulation of thrombin-binding sites in corneal endothelial cells, J Biol Chem 256 (1981), 4514-4519.
56. R. Schmidt, H. Schmidt and F. Fazekas, Vascular risk factors in dementia, J Neurol 247 (2000), 81-87.
57. P.C. Schulze and R.T. Lee, Oxidative stress and atherosclerosis, Curr Atheroscler Rep 7 (2005), 242-248.
58. J. Shi, G. Perry, M.A. Smith and R.P. Friedland, Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease, Neurobiol Aging 21 (2000), 357-361.
59. M. Simons, P. Keller, J. Dichgans and J.B. Schulz, Cholesterol and Alzheimer's disease: is there a link? Neurology 57 (2001), 1089-1093
60. I.V. Smirnova, S.X. Zhang, B.A. Citron, P.M. Arnold and B.W. Festoff, Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons, J Neurobiol 36 (1998), 64-80.
61. D. Stanimirovic and K. Satoh, Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation, Brain Pathol 10 (2000), 113-126.
62. D.M. Stern, I. Bank, P.P. Nawroth, J. Cassimeris, W. Kisiel, J. W. Fenton, C. Dinarello, L. Chess and E.A. Jaffe, Self-regulation of procoagulant events on the endothelial cell surface, J Exp Med 162 (1985), 1223-1229.
63. R. Stewart, M. Prince and A. Mann, Vascular risk factors and Alzheimer's disease, Aust N ZJ Psychiatry 33 (1999), 809-813.
64. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen and A.D. Roses, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA 90 (1993), 1977-1981.
65. D.G. Stupack and D.A. Cheresh, Integrins and angiogenesis, Cur Top Dev Biol 64 (2004), 207-238.
66. Z. Suo, M. Wu, B.A. Citron, R.E. Palazzo and B.W. Festoff, Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling, J Biol Chem 278 (2003), 37681-37689.
67. E.E. Tuppo and H.R. Arias, The role of inflammation in Alzheimer's disease, Int J Biochem Cell Biol 37 (2005), 289-305.
68. N.E. Tsopanoglou and M.E. Maragoudakis, On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by regulation of its receptors, J Biol Chem 274 (1999), 23969-23976.
69. V.L. Turgeon, C.E. Milligan and L.J. Houenou, Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo, J Neuropathol Exp Neurol 58 (1999), 499-504.